Analysis

Despite a recent share price decline, Summit Therapeutics finds itself at a pivotal moment, with significant insider purchases and bullish...

A wave of aggressive buying by major financial institutions has swept over Hims & Hers Health, Inc. Recent regulatory filings...

A new legal development has emerged from Zurich, casting a shadow over UBS Group AG's ongoing integration of Credit Suisse....

While operational setbacks typically trigger sell-offs, Lynas Rare Earths Ltd. is currently scripting a different narrative. The company's stock is...

European Lithium’s shares have been a standout performer this year, boasting gains exceeding 290% since January amid intense volatility. However,...

PayPal's stock has endured a volatile year, shedding more than 35% of its value since January. This decline has tested...

Biotechnology firm Codexis finds itself navigating a critical transition. Recent quarterly results paint a picture of significant revenue contraction, even...

Biotechnology firm Ocugen is facing intense selling pressure, with its stock price declining sharply in recent sessions. On Monday, the...

Strong quarterly performance and a significant new institutional investment are fueling optimism for Fidelity National Information Services (FIS). The financial...

A powerful rally propelled shares of Dutch semiconductor equipment giant ASML to a fresh 52-week peak on Tuesday, breaching the...